An FDA advisory panel will meet July 18 to consider a supplemental new drug application for the antipsychotic brexpiprazole, ...

There's an unmet need for effective treatments in PTSD, as current options include psychotherapy and the SSRIs sertraline and paroxetine (Paxil). These options carry various adverse effects, and the ...